- Home
- RNXT vs NUKK Comparison
RNXT vs NUKK Comparison
Compare RNXT & NUKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNXT
- NUKK
- Stock Information
- Founded
- RNXT 2012
- NUKK 2013
- Country
- RNXT United States
- NUKK United States
- Employees
- RNXT N/A
- NUKK N/A
- Industry
- RNXT Biotechnology: Pharmaceutical Preparations
- NUKK Blank Checks
- Sector
- RNXT Health Care
- NUKK Finance
- Exchange
- RNXT Nasdaq
- NUKK Nasdaq
- Market Cap
- RNXT 44.6M
- NUKK 37.7M
- IPO Year
- RNXT 2021
- NUKK N/A
- Fundamental
- Price
- RNXT $1.26
- NUKK $5.79
- Analyst Decision
- RNXT Strong Buy
- NUKK
- Analyst Count
- RNXT 2
- NUKK 0
- Target Price
- RNXT $7.50
- NUKK N/A
- AVG Volume (30 Days)
- RNXT 648.4K
- NUKK 11.7M
- Earning Date
- RNXT 11-12-2025
- NUKK 11-14-2025
- Dividend Yield
- RNXT N/A
- NUKK N/A
- EPS Growth
- RNXT N/A
- NUKK N/A
- EPS
- RNXT N/A
- NUKK N/A
- Revenue
- RNXT $662,000.00
- NUKK N/A
- Revenue This Year
- RNXT $2,895.35
- NUKK N/A
- Revenue Next Year
- RNXT $313.04
- NUKK N/A
- P/E Ratio
- RNXT N/A
- NUKK N/A
- Revenue Growth
- RNXT N/A
- NUKK N/A
- 52 Week Low
- RNXT $0.75
- NUKK $1.30
- 52 Week High
- RNXT $1.69
- NUKK $78.32
- Technical
- Relative Strength Index (RSI)
- RNXT 58.65
- NUKK 56.16
- Support Level
- RNXT $1.19
- NUKK $5.15
- Resistance Level
- RNXT $1.45
- NUKK $6.66
- Average True Range (ATR)
- RNXT 0.12
- NUKK 0.76
- MACD
- RNXT 0.02
- NUKK 0.25
- Stochastic Oscillator
- RNXT 62.75
- NUKK 52.38
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.
About NUKK Nukkleus Inc.
Nukkleus Inc is a financial technology company that is focused on providing software and technology solutions. The company's operating segment includes General support services and Financial services. General support services include providing software, technology, customer sales and marketing, and risk management technology hardware and software solutions package under a GSA to a related party. Financial services include providing payment services from one fiat currency to another or to digital assets. It generates maximum revenue from the General support services segment. Geographically operates in USA, UK and Malta, with majority of revenue from United Kingdom (UK).